AlphaMadera's AlphaVal page computes Miller Industries, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag MLR as undervalued, fairly valued, or overvalued.

What is Miller Industries, Inc.'s fair value?

Fair value for MLR is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value MLR?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from MLR's most recent reported fundamentals.

MLR - Miller Industries, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $50.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Mild

Trading 3.5% above fair value

Current Price $49.26

Bear Case $41.66 15.4% downside ($41.66 - $49.26) / $49.26 = -15.4% $2.98 × 14x P/E

Fair Value $47.62 3.3% downside ($47.62 - $49.26) / $49.26 = -3.3% $2.98 × 16x P/E

Bull Case $53.57 8.7% upside ($53.57 - $49.26) / $49.26 = 8.7% $2.98 × 18x P/E

Adjust Assumptions

P/E Multiple

16.0x

Adjusted EPS

2.98$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 16.6x

Plain-Language Summary

Applying a 16x P/E to adjusted EPS of $2.98, the base-case value is $47.62 per share. DDM cross-check: $15.69.

Warnings

⚠ The company's reported profits differ from official accounting profits by 50%. Check what costs are being left out of the adjusted number.

ℹ Dividend-based valuation: $15.69 (below our primary estimate by 67%). Large gaps may signal the dividend doesn't reflect full earning power.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples